false 0001626644 0001626644 2025-05-23 2025-05-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: May 23, 2025

(Date of earliest event reported)

 

ODYSSEY HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

Nevada 000-56196 47-1022125
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)

 

2300 West Sahara Avenue, Suite 800 - #4012,
Las Vegas, NV
89102
(Address of principal executive offices) (Zip Code)

 

(702) 780-6559

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
N/A N/A N/A

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each Class Trading Symbol Name of Each Exchange on Which Registered
Common Stock ($0.001 par value) ODYY OTC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

   

 

 

Item 8.01 Other Material Event

 

On May 23, 2025, Financial Industry Regulatory Authority (“FINRA”) approved Odyssey Group International, Inc.’s name change on the OTC Markets to Odyssey Health, Inc., effective as of May 27, 2025. The name change was approved by the shareholders at the September 14, 2021, annual shareholder meeting and was effectuated by the State of Nevada via an amendment to the issuer’s Articles of Incorporation filed December 1, 2021, and effective October 8, 2021.

 

The current OTC Market symbol ODYY remains the same.

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Odyssey Health, Inc.
   
Date: May 29, 2025 By:  /s/ Joseph Michael Redmond
    Joseph Michael Redmond
Chief Executive Officer

 

 

 

 

 

 3